Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 17,925 | 18,279 | 12,912 | 11,246 | 8,882 |
| Cost of Goods | 8,414 | 9,200 | 6,698 | 4,497 | 3,812 |
| Gross Profit | 9,511 | 9,079 | 6,214 | 6,749 | 5,070 |
| Operating Expenses | 20,385 | 24,391 | 22,468 | 21,074 | 19,173 |
| Operating Income | -10,460 | -15,112 | -15,556 | -13,828 | -13,291 |
| Interest Expense | 269 | 302 | 156 | 113 | 139 |
| Other Income | -601 | 216 | 632 | 4,177 | -2,395 |
| Pre-tax Income | -11,330 | -15,198 | -15,080 | -9,764 | -15,825 |
| Net Income Continuous | -11,330 | -15,198 | -15,080 | -9,764 | -15,825 |
| Net Income | $-11,330 | $-15,198 | $-15,080 | $-9,764 | $-15,825 |
| EPS Basic Total Ops | -8.40 | -16.49 | -17.39 | -11.99 | -33.13 |
| EPS Basic Continuous Ops | -8.43 | -16.43 | -17.44 | -12.01 | -33.12 |
| EPS Diluted Total Ops | -8.40 | -16.49 | -17.39 | -13.19 | -33.13 |
| EPS Diluted Continuous Ops | -8.43 | -16.43 | -17.44 | -11.93 | -33.12 |
| EPS Diluted Before Non-Recurring Items | -8.40 | -16.49 | -17.39 | -15.59 | -24.14 |
| EBITDA(a) | $-8,852 | $-13,414 | $-14,669 | $-12,805 | $-12,482 |